{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/lyme-disease/diagnosis/differential-diagnosis-erythema-migrans/","result":{"pageContext":{"chapter":{"id":"868a26b1-1742-50d5-8576-14ab327a0c64","slug":"differential-diagnosis-erythema-migrans","fullItemName":"Differential diagnosis (erythema migrans)","depth":2,"htmlHeader":"<!-- begin field 7e555dd1-7b9e-4efa-8bec-fe3c3989b387 --><h2>What else might it be?</h2><!-- end field 7e555dd1-7b9e-4efa-8bec-fe3c3989b387 -->","summary":"","htmlStringContent":"<!-- begin item 17e29df7-eb68-41a0-95ca-78de820d860c --><!-- begin field 821b2d6f-4593-4dae-84f9-11067f6fda21 --><ul><li><strong>Erythema migrans may be confused with:</strong><ul><li><strong>Tick bite hypersensitivity reaction. </strong><ul><li>An erythematous skin lesion presenting while the tick is still attached or which has developed within 48 hours of detachment is most likely to be a tick bite hypersensitivity reaction rather than erythema migrans.</li><li>Tick bite hypersensitivity reactions are usually less than 5 cm in diameter, and itchy; they sometimes have an urticarial appearance, and typically begin to disappear within 24–48 hours.</li></ul></li><li><strong>Hypersensitivity to an insect bite </strong>— develops rapidly, is often itchy, and is usually smaller than erythema migrans (see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/insect-bites-stings/\">Insect bites and stings</a>).</li><li><strong>Other skin conditions including</strong>:<ul><li><strong>Cellulitis</strong> — usually occurs on a limb or at site of skin trauma. It presents as uniform erythema, which is warm and painful, and has a faster onset than erythema migrans (see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cellulitis-acute/\">Cellulitis - acute</a>). It may be present at the same time as erythema migrans. For an image, see <a data-hyperlink-id=\"4688cf12-ce99-4ee4-ab6a-a91400e24964\" href=\"http://www.dermnetnz.org/doctors/bacterial-infections/cellulitis.html\">www.dermnetnz.org</a>.</li><li><strong>Erythema multiforme</strong> — appears as multiple target lesions (sometimes blisters). The lesions are small (less than 2 cm in diameter), diffuse, and symmetrical, with slow enlargement; palmar and mucosal involvement is common and there is often an obvious precipitant. For an image, see <a data-hyperlink-id=\"6af644ca-3b35-488d-866a-a91400e24b56\" href=\"http://www.dermnetnz.org/reactions/erythema-multiforme.html\">www.dermnetnz.org</a>.</li><li><strong>Granuloma annulare </strong>— is usually smaller than erythema migrans. The periphery is usually papular, and it can have central clearing. For an image, see <a data-hyperlink-id=\"8cb6b737-5d3a-4130-8bbc-a91400e24df9\" href=\"http://dermnetnz.org/dermal-infiltrative/granuloma-annulare.html\">www.dermnetnz.org</a>.</li><li><strong>Nummular eczema </strong>— lesions are usually smaller and less erythematous than erythema migrans. Does not enlarge rapidly, pruritic, well demarcated, skin may be thickened or weepy.</li><li><strong>Southern tick-associated rash illness (STARI)</strong> — is a similar rash to erythema migrans, and is seen in southern US.</li><li><strong>Spider bite (usually non-UK</strong>) — is often necrotic and very painful. For an image, see <a data-hyperlink-id=\"21b8f767-535d-40ad-94f5-a91400e24fc9\" href=\"http://dermnetnz.org/arthropods/spider-bites.html\">www.dermnetnz.org</a>.</li><li><strong>Tick-borne encephalitis</strong> —<strong> </strong>a tick-borne, flu-like, viral illness that starts 2–28 days after a tick bite. It can progress to meningitis, encephalitis, radiculitis, and myelitis, and can be fatal. It is common in central and eastern Europe, but is never acquired in the UK.</li><li><strong>Tinea (ringworm</strong>) — these lesions are characterized by scale and itch (see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/fungal-skin-infection-body-groin/\">Fungal skin infection - body and groin</a>). For an image, see <a data-hyperlink-id=\"d493cab5-f0bc-4f03-8bee-a91400e25153\" href=\"http://dermnetnz.org/fungal/tinea-corporis.html\">www.dermnetnz.org</a>.</li><li><strong>Urticaria </strong>— multiple raised lesions are nettle-like or blotchy, and very itchy. It usually resolves within 24–36 hours (see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urticaria/\">Urticaria</a>). For an image, see <a data-hyperlink-id=\"cb8e9ba3-016a-48e0-99b0-a91400e2533f\" href=\"http://www.dermnetnz.org/reactions/urticaria.html\">www.dermnetnz.org</a>.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">Shapiro, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/lyme-disease/references/\">BMJ, 2017</a>]</p><!-- end field 821b2d6f-4593-4dae-84f9-11067f6fda21 --><!-- end item 17e29df7-eb68-41a0-95ca-78de820d860c -->","topic":{"id":"56ba86e1-b79d-5c00-948b-65c581b69f79","topicId":"7aa291ec-f53e-44b9-8a66-e9b4ee6a577f","topicName":"Lyme disease","slug":"lyme-disease","lastRevised":"Last revised in August 2019","chapters":[{"id":"5995c194-77ea-5203-83e7-86b64985db74","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cc168196-a2da-5a8f-873c-fb75c4c3960f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a8622b23-7f1f-543b-b5ba-e9f4c9547c1c","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4c25a599-a26d-5702-b9f6-43dff73c83c8","slug":"changes","fullItemName":"Changes"},{"id":"29379f04-710e-5ce7-ba07-ea9a1e178ac7","slug":"update","fullItemName":"Update"}]},{"id":"bc55cfd2-4253-598a-8be1-54061ce22b6a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"49a7229f-6129-58a8-9b6e-7471ccde1b15","slug":"goals","fullItemName":"Goals"},{"id":"ca83767e-8bdd-5ab2-b78a-c8577ab6da08","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"928ab402-0b5e-53b7-96d3-a64275903911","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d5230b0a-b405-5725-9a8a-95f4a63239e1","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a9b48f27-60ba-54c9-9deb-e1ce41732fc9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5cc0f690-6775-5131-a1fc-75d9efa0b535","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8bbfecb1-6cb7-511b-9697-7915788a4bff","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"1c94f9ce-3656-59d3-86ed-d515d113270a","slug":"definition","fullItemName":"Definition"},{"id":"1a4679d0-b6d3-5b97-917c-5d08de1be33b","slug":"causes","fullItemName":"Causes"},{"id":"6e585a22-8dfe-578a-99a9-1be143896b7f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e1ded21e-6325-5c18-ae0a-6b540cd28c19","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"126215ba-45c3-5bbf-ae98-2fff7bb1ed89","slug":"prognosis","fullItemName":"Prognosis"},{"id":"5240144c-4a60-5d30-ab1e-63d4f2995a2f","slug":"complications","fullItemName":"Complications"},{"id":"a5092448-11ae-5b17-8a6b-8b6f6d5b80cf","slug":"other-tick-borne-diseases","fullItemName":"Other tick-borne diseases"}]},{"id":"d2ae2f81-2546-5ff8-8002-577ff4741f57","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"0cf6a4b7-b848-5424-b311-ae2e70bf1cf4","slug":"when-to-suspect-lyme-disease","fullItemName":"When to suspect Lyme disease"},{"id":"868a26b1-1742-50d5-8576-14ab327a0c64","slug":"differential-diagnosis-erythema-migrans","fullItemName":"Differential diagnosis (erythema migrans)"}]},{"id":"1a2edd0e-8cc2-5cce-aa6f-5519b5f40775","fullItemName":"Management","slug":"management","subChapters":[{"id":"35e8dbb5-da7f-5fd3-9ff3-b9926f24ed6e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"8d378757-a1b8-5c8c-95b4-d1428557dcb3","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"10094473-f953-57de-8453-10fc5a4709a2","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"714c78fe-f533-5abf-8ab9-28bdb2658044","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"245cb0af-f052-5aa2-8912-6e553063438e","slug":"azithromycin","fullItemName":"Azithromycin"}]},{"id":"98b0aa55-4436-555a-bfde-05ef12f03083","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0edcddd4-56b7-5124-b56a-14f7a38f3fd5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d42dec32-1352-5fb5-8d7d-c3591bae0448","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"254e7467-a025-51bb-849c-803edae01e3b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"659f6620-1672-5b1d-bf3e-891ce69b4ff1","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fdc13e77-5b9e-59a9-b651-15a5e1b1f333","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ccedf4e2-7c6a-5251-abee-5f5f14e5ed39","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a2095079-fcfd-5a3f-85e9-d631c57dd891","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d2ae2f81-2546-5ff8-8002-577ff4741f57","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}